EchoStar Corporation Class A ist eine Aktie aus dem Premium-Bereich von aktien.guide. Bitte anmelden, um einen Alarm für EchoStar Corporation Class A zu aktivieren.
Kostenlos registrieren
Bitte registriere Dich kostenlos, um EchoStar Corporation Class A zu Deinem Portfolio hinzuzufügen.
EchoStar has sold another $2.6 billion in spectrum to Elon Musk's SpaceX, giving the wireless and pay-TV company a stake of about 3% that is currently worth $11 billion. The transaction, announced Thursday along with the company's third-quarter results, builds on a $17 billion spectrum deal between the companies last September.
EchoStar Corporation ( SATS ) Q3 2025 Earnings Call November 6, 2025 11:00 AM EST Company Participants Dean Manson - Chief Legal Officer & Secretary Hamid Akhavan - CEO, President & Director Charles Ergen - Co-Founder & Executive Chairman of the Board Conference Call Participants John Hodulik - UBS Investment Bank, Research Division Brent Penter - Raymond James & Associates, Inc., Research Divi...
EchoStar's third-quarter loss widened due to lower revenue and a charge on its multibillion-dollar sales of wireless spectrum, and the company appointed a new CEO.
EchoStar said it would sell a set of wireless spectrum licenses to SpaceX for about $2.6 billion in exchange for stock in the space startup, expanding on the $17 billion deal the companies struck in September.
EchoStar Capital Division Announced to Spearhead Future Growth Opportunities Wireless: Net subscriber growth (+223K), improved churn (2.86%, an improvement of 13 basis points year-over-year), improved average revenue per user (ARPU) (2.6% year-over-year) and continued to have the highest prepaid ARPU in the industry. Pay-TV: DISH TV churn (1.33%) is at a historic low for the third quarter, grow...
With this unpaired AWS-3 spectrum, in addition to the AWS-4 and H-block spectrum licenses, SpaceX to develop and deploy a next-generation Starlink Direct to Cell constellation. ENGLEWOOD, Colo.
AI-driven tech stocks dominate 2025 returns, leaving dividend and high-yield ETFs lagging due to limited AI exposure. REITs face mixed fortunes: ARE and DOC struggle with life science oversupply, while IVT, AMT, ADC, and VICI offer attractive dividend growth and value. My current buy list focuses on undervalued REITs and ETFs with strong dividend growth.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.